1.Influence of Chinese Medicine on Life Span of Middle-late Primary Hepatic Carcinoma Patients:A Multicenter Retrospective Cohort Study
Yiwen QIU ; Lizhu LIN ; Xuewu HUANG ; Shutang WANG ; Meng LI
Journal of Guangzhou University of Traditional Chinese Medicine 2014;(5):699-705
Objective To investigate the influence of Chinese medicine ( CM) treatment on life span of middle-late primary hepatic carcinoma (PHC) patients. Results A multicenter retrospective cohort study was carried out in 489 PHC patients at the stages of Ⅱb, Ⅲa and Ⅲb collected from 15 domestic hospitals. With CM treatment as the exposure factor, the enrolled patients were divided into CM group, western medicine (WM) group and the CM-WM combination group. The main outcomes included median survival time (MST) and survival rate, and the effects of CM treatment and minimally invasive therapy on MST were observed. Results Half-a-year survival rate, one-year survival rate and two-year survival rate were 50%, 9%, 1% in CM group, 70%, 30%, 6% in CM-WM combination group, and 50%, 10%, 0% in WM group, respectively. The survival rates in CM-WM combination group differed from those in CM group and WM group (P<0.01), but the differences of survival rates between CM group and WM group were insignificant (P>0.05) . MST at the stages of Ⅱb, Ⅲa, Ⅲb in CM-WM group was obviously prolonged as compared with the other two groups (P<0.01), and MST at the stages of Ⅲa, Ⅲb in CM group was also obviously prolonged as compared with WM group (P<0.05) . The difference of MST at the stage of Ⅱb was insignificant between CM group and WM group ( P>0.05) . CM treatment and minimally invasive therapy were effective on prolonging the survival time of PHC patients ( P<0.01) . The results of COX regressionanalysis showed that Karnofsky scores, CM treatment and minimally invasive therapy were the preventive factors for the prognosis. Conclusion CM-WM combination group has the best long -term therapeutic effect. CM -WM combination treatment is effective on increasing MST and long-term survival rate, in particular for PHC patients at the stages ofⅡb, Ⅲa and Ⅲb. CM treatment and minimally invasive therapy are helpful for the prolongation of the survival time of PHC patients.
3.Clinical Observation on Preventive Effect of Oxiliplatin Induced Peripheral Neuropathy by Fumigation of Siteng Yixian Decoction
Jingwen JIANG ; Xuewu CHEN ; Hongbing CAI ; Lin WANG ; Yingjin FU ; Rongcheng LUO
Journal of Nanjing University of Traditional Chinese Medicine 2015;(5):420-423
ABSTRACTOBJECTIVE To observe the preventive effect of oxaliplatin induced peripheral neuropathy treated by fumigation of Siteng Yixian decoction.METHODS Totally 150 colorectal cancer patients from oncology department Of Hainan provincial hospital of TCM between January 2010 and December 2014 were enrolled in this study.And they were randomized into two groupswith 75 cases in each.The patients in the control group only received oxaliplatin based chemotherapy.While the pa-tients in the treatment group were given the chemotherapy combined with fumigation of Siteng Yixian decoction.The fumiga-tion lasted for forty minutes a timetwice a day.After the treatment of two cycles chemotherapythe incidence rate and sever-ity classification of peripheral neuropathy was analyzed one month later to evaluate the preventive effect.RESULTS The difference of incidence rate of peripheral neuropathy was significantwith the rate being 18.7% in the treatment group and 56. 0% in the control groupP <0.01.The severity classification was evidently higher in the control group90.37than those in the treatment group60.63and there exised a statistical significanceP <0.05.Among the patients who had second degree peripheral neuropathy or abovethe oxaliplatin accumulative dose was1 054.76±124.6in the treatment group and823.47 ±190.67 in the control groupand the difference was statistically significantP <0.05.Logistic regression indicated that fu-migation of Siteng Yixian decoction was the protective factor for the oxaliplatin?induced peripheral neuropathy.CONCLUSION Fumigation of Siteng Yixian decoction can reduce the incidence ratedecline the severity classification of oxaliplatin?induced peripheral neuropathy and increase the oxaliplatin tolerance dose.It is the independent preventive factor for oxaliplatin?induced peripheral neuropathy.
4.Clinical efficacy of ultrasound-guided paravertebral nerve block combined with platelet rich plasma injection for postherpetic neuralgia
Journal of Chinese Physician 2024;26(9):1299-1303
Objective:To investigate the clinical therapeutic effect of ultrasound-guided paravertebral nerve block combined with platelet rich plasma (PRP) injection on patients with postherpetic neuralgia (PHN).Methods:Sixty PHN patients diagnosed at the First Affiliated Hospital of Bengbu Medical University from August 2023 to June 2024 were selected and randomly divided into a control group and an observation group using a random number table. The control group received ultrasound-guided paravertebral nerve block, while the observation group received PRP injection in addition to the control group. The two groups were compared before treatment (T 0), 1 week after treatment (T 1), 2 weeks after treatment (T 2), 3 weeks after treatment (T 3), 4 weeks after treatment (T 4), and 8 weeks after treatment (T 5), pain Visual Analogue Scale (VAS), Pittsburgh Sleep Quality Index (PSQI), Dermatology Quality of Life Index (DLQI) scores, and incidence of adverse reactions at each time point. Results:The pain VAS, PSQI, and DLQI scores of both groups of patients at T 1, T 2, T 3, T 4, and T 5 time points were reduced compared to T 0, and the pain VAS, PSQI, and DLQI scores of the observation group at T 1 to T 5 time points were lower than those of the control group (all P<0.05). The incidence of adverse reactions in the control group was 26.6%(8/30), while in the observation group it was 6.6%(2/30), with a statistically significant difference between the two groups (χ 2=4.320, P<0.05). The total effective rate of the control group [70.0%(21/30)] was lower than that of the observation group [93.3%(28/30)], with a statistically significant difference between the two groups (χ 2=5.454, P<0.05). Conclusions:The combined application of ultrasound-guided paravertebral nerve block and PRP injection for the treatment of PHN can significantly alleviate patients′ pain symptoms, improve their sleep and quality of life, with relatively few side effects and high safety.
5.Effectiveness and safety of Kang′ai injection combined with single agent chemotherapy in treatment of el-derly patients with advanced NSCLC
Hanrui CHEN ; Huaqin TIAN ; Zhiming CHEN ; Xuewu HUANG ; Xinting ZHENG ; Xuezhang CHEN ; Lizhu LIN
The Journal of Practical Medicine 2018;34(2):316-319
Objective To observe the effectiveness and safety of Kang′ai injection combined with docetaxel or gemcitabine chemotherapy in treatment of elderly patients with advanced non-small cell lung cancer(NSCLC). Methods A multi-center,randomized and parallel control study was carried out in 150 elderly patients with ad-vanced NSCLC treated in 3 hospitals during the period from June 2013 to August 2014.The patients were randomly divided into platinum-based group(platinum-based doublet chemotherapy)and Kang′ai group(Kang′ai injection combined with single agent chemotherapy). The clinical efficacy,quality of life and adverse reactions were ob-served and compared between the two groups. Results There was no significant difference in the disease control rate between the two groups group(79.66% vs 81.82%)(χ2=0.101,P=0.751)while the effective rate of Kang′ai group was significantly higher than that of platinum-based group(30.51% vs 14.29%)(χ2=5.240,P=0.022). The effective rate of clinical symptom relief in Kang′ai group after treatment was significantly higher than that in platinum-based group(69.49% vs 48.05%)(χ2=6.278,P=0.012),and the increase rate of PS score in Kang′ai group after the treatment was also significantly higher than that in platinum-based group(18.64% vs 3.90%)(χ2=7.868,P=0.005).There was no significant difference in quality of life between two groups(P>0.05).The quali-ty of life score of Kang′ai group was significantly higher than that of platinum-based group at the second course of treatment(P<0.05).The incidence of adverse reactions in Kang′ai group was significantly lower than that in the platinum-based group(47.46% vs 71.42%)(χ2= 8.070,P < 0.05). Conclusion Kang′ai injection combined with single agent chemotherapy can effectively relieve clinical symptoms and reduce the tumor size in elderly patients with advanced NSCLC,with high safety.
6.Analysis of influencing factors of portal vein tumor thrombus in primary liver cancer
Jing XU ; Lin TAN ; Xuewu GAO ; Jinling WANG ; Fengcheng LI
Cancer Research and Clinic 2018;30(9):610-612,616
Objective To investigate the influencing factors of portal vein tumor thrombus in patients with primary liver cancer(PLC).Methods A total of 483 patients with PLC in the Second People's Hospital of Fuyang from January 2012 to December 2016 were included in this retrospective study.Univariate analysis and multi-variate logistic regression analysis were employed to analyze the association between portal vein tumor thrombus and routine clinical parameters.Results The univariate analysis showed that alanine aminotransferase,aspartate aminotransferase,total bilirubin,γ-glutamyltranspeptidase,alkaline phosphatase,alpha-fetoprotein,the size and the number of tumors,ascites and center location of cancer performed a close relationship with the formation of portal vein tumor thrombus in patients with PLC,and the differences were statistically significant(P values were 0.010,0.000,0.010,0.000,0.001,0.000,0.000,0.004 and 0.010).Multivariate logistic regression analysis showed that potential significant predictors of portal vein tumor thrombus in patients with PLC were alpha-fetoprotein and ascites,and the differences were statistically significant(P values were 0.000 and 0.040).Conclusion PLC patients with high level of alpha-fetoprotein and ascites are easier to induce the formation of portal vein tumor thrombus.